In Vitro Stimulation and Visualization of Extracellular Trap Release in Differentiated Human Monocyte-derived Macrophages
November 1st, 2019
9.9K views
Presented here is a protocol to detect macrophage extracellular trap (MET) production in live cell culture using microscopy and fluorescence staining. This protocol can be further extended to examine specific MET protein markers by immunofluorescence staining.
Overview
This protocol outlines a method to detect macrophage extracellular trap (MET) production in live cell culture using microscopy and fluorescence staining. It also allows for the examination of specific MET protein markers through immunofluorescence staining.
Key Study Components
Area of Science
- Neuroscience
- Immunology
- Cell Biology
Background
- Extracellular traps are released by immune cells and play a role in innate immunity.
- Macrophages are critical in the inflammatory response but their MET production is less understood.
- This protocol uses primary human cells, providing a more physiologically relevant model.
- No priming step is needed to differentiate monocytes into macrophages, unlike other cell lines.
Purpose of Study
- To provide a reliable in vitro model for studying MET production in macrophages.
- To explore the physiological growth of MET structures in vivo.
- To enhance understanding of macrophage functions in inflammation.
Methods Used
- Isolation of primary human macrophages from buffy coat preparations.
- Microscopy for visualizing MET production.
- Fluorescence staining for detecting MET markers.
- Immunofluorescence staining for specific protein analysis.
Main Results
- Successful detection of MET production in live macrophage cultures.
- Identification of specific MET protein markers through immunofluorescence.
- Demonstration of the protocol's effectiveness using primary human cells.
- Insights into the role of macrophages in inflammatory responses.
Conclusions
- This protocol provides a valuable tool for studying macrophage MET production.
- It highlights the importance of using primary cells for physiological relevance.
- The findings may contribute to a better understanding of macrophage functions in health and disease.
Frequently Asked Questions
What are macrophage extracellular traps?
Macrophage extracellular traps (METs) are structures released by macrophages that trap and kill pathogens, playing a role in the immune response.
Why is it important to study METs?
Studying METs helps understand their role in inflammation and immune responses, which can inform therapeutic strategies for inflammatory diseases.
How are primary human macrophages obtained for this protocol?
Primary human macrophages are isolated from buffy coat preparations, which contain a mixture of blood components.
What microscopy techniques are used in this protocol?
The protocol utilizes fluorescence microscopy to visualize MET production in live cell cultures.
Can this protocol be adapted for other cell types?
While this protocol is designed for macrophages, similar techniques may be adapted for other immune cell types.
What is the advantage of using primary cells over cell lines?
Primary cells provide a more accurate representation of in vivo conditions, leading to more relevant biological insights.
Executive Industry Relevance
This protocol provides a primary human macrophage model to visualize extracellular trap release, enabling mechanistic de-risking of inflammatory pathways in target validation. By using freshly isolated human monocyte-derived macrophages, it supports predictive confidence in preclinical models of chronic inflammation. The approach facilitates translational biomarker screening and assay development for immunomodulatory therapeutics.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of macrophage extracellular trap formation as a therapeutic hypothesis in chronic inflammatory diseases.
- Operational Value: Uses primary human cells to reduce species translation risk and improve target validation fidelity.
- Predictive Value: Supports functional assessment of immunomodulators on MET release, aiding in lead identification and portfolio triage.
Screening & Assay Development
- Scientific Value: Provides a quantitative fluorescence-based readout for MET release using SYTOX green staining.
- Operational Value: Delivers a reproducible, microscopy-compatible assay format suitable for compound screening campaigns.
- Scalability: Adaptable to human monocyte cell lines (e.g., THP-1) and murine models for cross-species target validation.
Translational & Preclinical Research
- Scientific Value: Allows comparison of MET release across macrophage phenotypes (M1 vs M2) to inform disease-relevant mechanism of action.
- Operational Value: Generates visual and quantifiable extracellular DNA readouts compatible with downstream qPCR analysis.
- Translational Continuity: Uses primary human cells to model in vivo inflammatory events, enhancing clinical relevance of preclinical findings.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target hypothesis testing through lead optimization to preclinical validation, particularly for immunomodulatory and anti-inflammatory programs.
- Discovery Biology: Supports hypothesis-driven testing of macrophage extracellular trap formation in response to inflammatory stimuli.
- Screening: Enables standardized, fluorescence-based assessment of MET release for compound effect profiling.
- Analytics: Produces imaging and nuclear/mitochondrial DNA quantification outputs for comparative condition analysis.
- Translational Research: Connects in vitro MET release to pathophysiological mechanisms in chronic inflammation via primary human cell models.
- Enterprise Reuse: Establishes a reusable primary cell platform for immunology and inflammation target validation across therapeutic areas.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence by modeling human macrophage extracellular trap biology in a physiologically relevant system.
- Operational Value: Delivers a standardized, imaging-compatible protocol with defined stimulation and fixation conditions.
- Strategic Value: Reduces late-stage biological risk by enabling early de-risking of macrophage-mediated inflammatory mechanisms.
- Portfolio Impact: Informs go/no-go decisions by providing mechanistic insight into immunomodulator effects on extracellular trap formation.
Implementation Considerations
- Requires expertise in primary human cell culture, sterile technique, and fluorescence microscopy.
- Dependent on access to human buffy coat sources and cytokine reagents (IFN-γ, LPS, IL-4, PMA, TNF-α, IL-8, hypochlorous acid).
- Necessitates standardized incubation, stimulation, and washing steps to preserve extracellular trap integrity.
- Requires optimization of SYTOX green concentration and imaging settings to distinguish specific MET release from nonspecific dye uptake.
- Limited by the fragility of extracellular traps, demanding careful handling between steps to avoid structural disruption.
Biopharma FAQs
Why is SYTOX green used to visualize MET release?
SYTOX green is a cell-impermeant nucleic acid stain that labels extracellular DNA released during macrophage extracellular trap formation, enabling specific visualization of METs via fluorescence microscopy.
How does M1 polarization affect MET release in human macrophages?
M1 polarization with interferon gamma and lipopolysaccharide primes human monocyte-derived macrophages to release extracellular traps upon stimulation with agents like PMA, TNF-alpha, IL-8, or hypochlorous acid.
What stimulation conditions trigger MET release in differentiated macrophages?
MET release is induced by exposure to phorbol myristate acetate (PMA), tumor necrosis factor-alpha (TNF-alpha), interleukin-8 (IL-8), or hypochlorous acid in M1-polarized human monocyte-derived macrophages.
Why are primary human macrophages preferred over cell lines for MET studies?
Primary human monocyte-derived macrophages provide a more physiologically relevant model than immortalized lines, reducing artifacts and improving translational relevance for inflammatory disease modeling.
How is MET release quantified beyond fluorescence imaging?
Extracellular DNA released as part of METs can be quantified using qPCR analysis of nuclear and mitochondrial DNA present in the cell culture supernatant following stimulation.
Chapters in this video
0:05
Title
1:35
Polarization of HMDM (Human Monocyte-derived Macrophages)
2:36
Stimulation of HMDM to Induce MET (Macrophage Extracellular Traps) Release
4:20
Visualization of MET in Live Cell Culture
5:46
Results: Morphological Changes of Differentially Polarized HMDMs and Release of METs Following Stimulation
7:17
Conclusion
